This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BACKGROUND:Although lower hemoglobin levels associate with worse intracerebral hemorrhage (ICH) outcomes, causal drivers for this relationship remain unclear. Similar relationships were seen with poor 6- and 12-month outcomes. Additional studies are required to clarify whether correcting anemia can improve these outcomes.
In this study, we aim to study trends in EC-IC bypass throughout the years.Methods:Using the National Inpatient Sample 2016-2019, hospital admissions with carotid occlusive disease (COD), moyamoya, subarachnoid hemorrhage (SAH), unruptured intracranial aneurysm (UIA) were identified using ICD-10 diagnosis codes.
Our study aims to describe the trends and outcomes of patients with Subarachnoid Hemorrhage (SAH) using a Nationwide Inpatient Sample (NIS) database.Methods:We examined the 2016-2020 NIS database, focusing on patients aged 18 years and older with a primary SAH discharge diagnosis. years with 72,650 (61.0%) being female.
BACKGROUND:Sex-specific differences in stroke risk factors, clinical presentation, and outcomes are well documented. Primary end points were 90-day readmission for ischemic stroke or hemorrhage and compared between men and women.
We investigated the efficacy and safety of treatment with each of 4 different DOACs or warfarin after DOAC failure.Methods and ResultsWe retrospectively analyzed patients with atrial fibrillation with ischemic stroke despite DOAC treatment between January 2002 and December 2016. 0.39] for apixaban, 0.23 [95% CI, 0.14–0.37]
Racial and ethnic disparities in risk factors and outcomes for young patients with ischemic stroke (AIS) are well described. Less is known about disparities in risk and outcomes for young patients presenting with intracerebral hemorrhage (ICH), which is associated with higher short-term and long-term mortality. Asian, and 5.1%
BackgroundDelayed cerebral ischemia represents a significant contributor to death and disability following aneurysmal subarachnoid hemorrhage. The lack of standardized experimental setups and outcome assessments, particularly regarding secondary vasospastic/ischemic events, may be partly responsible for the translational failure.
Background:Cerebral vasospasm is a well-known complication after aneurysmal subarachnoid hemorrhage (aSAH) and occurs more commonly in younger patients. Worse outcome was defined as 3-month modified Rankin Scale 4-6. Vasospasm was defined based on transcranial Doppler (TCD) criteria. years [SD 13.3], 65% female and 70% white).
Introduction:Cerebral amyloid angiopathy (CAA) is a common cause of intracerebral hemorrhage in elderly patients. Whether CAA is associated with isolated subdural hemorrhage (SDH), without an accompanying intracerebral hemorrhage, remains unclear. Stroke, Volume 56, Issue Suppl_1 , Page A139-A139, February 1, 2025.
Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (>=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH).
BACKGROUND:Shorter times to initiate antihypertensive and anticoagulation reversal treatments enhance their benefits in acute intracerebral hemorrhage (ICH). Stroke, Ahead of Print. Improving workflows to optimize time performance metrics is strongly advocated.
Background:FDA clearance of fully automated artificial intelligence (AI)-based software for quantifying intracerebral hemorrhage (ICH) volumes has the potential to meaningfully impact the acute management of hemorrhagic stroke. Quantifying ICH volume in OAC-related ICH presents challenges due to variability of morphology and density.
Objective:Socioeconomic disparities significantly affect the treatment and outcomes of cardiovascular and cerebrovascular diseases, including acute ischemic stroke. SES was assessed by matching patient ZIP codes to median household income data from the Census for the years 2016-2022.
In this study, we wanted to see the prevalence of ischemic or hemorrhagic stroke in patients with metastatic cancer to the brain, the demographic characteristics, and associated comorbidities.Methods:We conducted a retrospective analysis using the National Inpatient Sample Database from 2016 to 2020.
Background and Aims:Previous studies indicated the usual dose heparin(5000 IU bolus followed by 500~1250 IU/h) during mechanical thrombectomy(MT) is associated with an increased risk of hemorrhagic conversion without beneficial effect. vs 21.3%, p=0.04).
Background:While predictors of seizure in aneurysmal subarachnoid hemorrhage (aSAH) patients have been explored, predictors for seizure in patients with angiogram-negative non-perimesencephalic SAH (an-NPSAH) are less understood. Neither intracerebral hemorrhage nor aneurysm securement modality was associated with seizure.
Background:We identified that major ABO incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet the driver for this relationship is unknown and does not appear to be related to impaired hemostasis. Conversely, acute ICH patients are known to develop remote ischemic lesions on brain MRI.
Whereas secondary analyses from randomized trials have demonstrated no differences in thrombectomy outcomes in transferred vs direct presentation strokes (1‐2), several registry based cohorts reported worse functional outcomes in those with transferred presentation mode (3‐4).
We performed this analysis to identify the prevalence of atrial fibrillation and associated outcomes in symptomatic internal carotid artery stenosis patients undergoing CAS or CEA.Methods:We analyzed the data from the National inpatient sample (NIS) between January 2016 to December 2021. versus 18.8%
Introduction:Impact of race on outcomes in the treatment of intracranial aneurysm (IA) remains unclear. Data from 9 centers in the United States, Europe, and Asia for IA patients who undertook endovascular treatment (EVT) or microsurgical treatment (MST) between January 2016 and December 2020 were included for analysis. P< 001).
BACKGROUND:Patient-reported outcome measures (PROMs) describe health status from the perspective of the patient. Using the trial’s primary publication and protocol, we abstracted key study characteristics including all primary and secondary outcome measures. Only 1 trial used a PROM as a primary outcome.
There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. We aimed to investigate the impact of COVID‐19 on the overall complications, including ischemic stroke and subarachnoid hemorrhage (SAH) rates in patients treated for intracranial aneurysms (IAs).MethodsThis
Background:Utilizing medical claims derived information, we evaluated temporal trends in post-acute care utilization pathways among patients with acute ischemic stroke (AIS) or intracerebral hemorrhage (ICH).Methods:Data Analytical sample included all Medicare enrollees with a primary discharge diagnosis (AIS or ICH) from 2016 to 2020.
Background:Cisternal score (CISCO), which is calculated based on quantification of blood clot in basal cisterns, has been shown to have good accuracy in predicting ventriculoperitoneal shunt requirement in patients with aneurysmal subarachnoid hemorrhage (aSAH). Data was collected prospectively as part of a quality improvement project.
As the eligibility criteria for MT ease, more patients will undergo the procedure who have risk factors for complications such as malignant edema or hemorrhagic conversion that require decompressive craniectomy (DC).
The hospitals were grouped into quartiles based on the volume of MT procedures performed within the calendar year. The hospitals were grouped into quartiles based on the volume of MT procedures performed within the calendar year.
IntroductionUnderstanding of patient benefit and improvement following mechanical thrombectomy in ischemic stroke has made tremendous strides in recent years, however clinicians still struggle to accurately predict patient outcomes and long‐term neurological functioning following large vessel occlusion and endovascular therapy.
Specific aspects of IRF care driving better vascular outcomes need further evaluation. Objectives:We evaluate the potential link between post-acute care, particularly care provided at inpatient rehabilitation facilities (IRF) (vs. Conclusions:Post-acute care at an IRF (vs.
Introduction:There is no established acute intervention for central retinal artery occlusion (CRAO) which often results in poor visual outcomes. There was no difference in sICH, vitreous hemorrhage, or neovascularization.Conclusions:This is the first case series comparing CRAO treated with TNK, tPA, and MM.
Introduction:Pregnancy and the postpartum period are associated with an increased risk of ischemic and hemorrhagic strokes. Stroke, Volume 55, Issue Suppl_1 , Page ATP273-ATP273, February 1, 2024.
Massive Transfusion for Motorcycle Collision with Hemorrhage, Troponin Elevated. Atrial fibrillation is also a predictor of worse outcomes in this case (Alborzi). 2016, April 13). : A Child with Blunt Trauma -- See how the ECG can be definite for myocardial contusion, but subtle, and what happens if you miss it. Zangouri, V.,
Many studies have aimed to determine if heart failure (HF) is an independent risk factor in the development of AIS, but there is a paucity of literature describing the interventions and functional outcomes in this group of patients. AIS patients with CM and HF were compared to those without. 5.6%, p < 0.001) and EVT and tPA (0.9%
to identify patients with a diagnosis of AVM from the statewide inpatient and emergency department databases of Florida, Georgia, Maryland, New York, and Washington (2016-2019). Patients with a history of primary intracerebral hemorrhage or subarachnoid hemorrhage at baseline were classified as ruptured AVM (rAVM) patients.
Further study of outcomes among diverse populations of stroke surrogate decision-makers may help to identify sources of strength and resiliency that may be broadly applicable. Surrogates self-identified as being involved in decisions about do-not-resuscitate orders, brain surgery, ventilator, feeding tube, or hospice/comfort care.
BackgroundTransport by mobile stroke units (MSUs), which provide access to computed tomography scanning and intravenous blood pressure medications and thrombolytics, reduces time to treatment and may improve shortterm functional outcomes for patients with acute stroke. had an intracerebral hemorrhage, and 31.1% versus 15.1%,P=0.86).
Introduction:White matter hyperintensity (WMH) burden is associated with poor cognitive and functional outcomes after intracerebral hemorrhage (ICH). Stroke, Volume 56, Issue Suppl_1 , Page AWP199-AWP199, February 1, 2025. Deep-learning models provide a potential alternative to quantify WMH burden.
Introduction:There has been limited study of outcomes among surrogate decision makers who make decisions on life-sustaining treatments after severe stroke. Patient characteristics were mean age: 74.6, Female: 51.8%, Mean NIHSS: 14.7, deceased at 3 months: 53.1%. Surrogate characteristics were mean age: 55.8,
Our primary outcome was post-discharge LTFU, defined as having zero post-discharge encounters within 12 months. Our secondary outcomes included having one or more outpatient visits with a provider, unplanned hospitalizations, and emergency department (ED) visits within 30 days post-discharge. vs. 47.4%); have an intracerebral (12.1%
Background:Non-contrast computed tomography (NCCT) markers have been commonly used to characterize hematomas in intracerebral hemorrhage (ICH). Univariate and multivariate analyses were performed between CT markers and variables of operative outcome with R v 4.3.1.Results:221 Results:221 patients met the inclusion criteria.
The study outcome was a new speech pathology (SLT), occupational therapy (OT), or physical therapy (PT) encounter during the first year after discharge.Results:57,647 total cases were identified with 30% Medicare FFS, 33% Truven (Commercial) Medicare Advantage plan (65 years and older), and 37% Truven commercial (less than 65 years old).
Chi-square or Fisher’s exact test were used for categorical variables; Wilcoxon’s rank sum test was used for the outcomes of SRT to bolus and SRT to puncture.Result:We identified 196 IHS who received emergent treatment: 58 (30%) in Pre and 138 (70%) in Post Intervention (p=0.05). There was no difference in baseline demographics.
Our primary study outcome was any stroke or major thrombotic event identified within 60 days of OHSS diagnosis in HCUP or during the index admission for OHSS in NIS. The low rate of outcome events after OHSS seen in each of our population-level analyses increases the reliability of these study results. were included from each dataset.
Data was compared to a previous review period (01/2016-12/2018; comprised of 8 spokes) and the statewide IVT rates recorded in GWTG. Symptomatic hemorrhage (sICH) was 3.0%, overall 30-day mortality was 5.6%, and sICH mortality was 1.0%. 39% (410/1055) of eligible patients were treated with IVT (vs.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content